The potential role of mycotoxins as a contributor to stunting in the SHINE Trial

Clinical Infectious Diseases

Volumn 61, Issue , 2015, Pages S733-S737

  Smith, Laura E ^a   Prendergast, Andrew J ^b,c   Turner, Paul C ^d   Mbuya, Mduduzi N N ^a,c   Mutasa, Kuda ^c   Kembo, George ^e   Stoltzfus, Rebecca J ^a  

^a Cornell University ^*  (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Zvitambo Institute for Maternal and Child Health Research   (Zimbabwe)

^d UNIVERSITY OF MARYLAND   (United States)

^e Food and Nutrition Council   (Zimbabwe)

Author keywords

aflatoxin; deoxynivalenol; fumonisin; mycotoxin; stunting

Indexed keywords

AFLATOXIN; FUMONISIN; SOMATOMEDIN C; VOMITOXIN; MYCOTOXIN;

AGRICULTURAL PROCEDURES; ANEMIA; ARTICLE; BODY HEIGHT; CHILD GROWTH; CHILD HEALTH; CROP MANAGEMENT; DEVELOPING COUNTRY; DISEASE SEVERITY; ENTEROPATHY; ENVIRONMENTAL ENTERIC DYSFUNCTION; ENVIRONMENTAL EXPOSURE; FECES MICROFLORA; GROWTH RATE; HARVESTING; HUMAN; INFANCY; INTESTINE ABSORPTION; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; STUNTING; CLINICAL TRIAL; EATING; FEMALE; FOOD CONTAMINATION; GROWTH DISORDER; INFANT; MALE; METHODOLOGY; MICROBIOLOGY; RURAL POPULATION; ZIMBABWE;

EATING; FEMALE; FOOD CONTAMINATION; GROWTH DISORDERS; HUMANS; INFANT; MALE; MYCOTOXINS; RESEARCH DESIGN; RURAL POPULATION; ZIMBABWE;

EID: 84950322815     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ849     Document Type: Article

References (44)

1. Turner PC, Flannery B, Isitt C, Ali M, Pestka J. The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr Res Rev 2012; 25:162-79.
2. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial: Rationale, design, and methods. Clin Infect Dis 2015; 61(suppl 7):S685-702.
3. Prendergast A, Mutasa K, Rukobo S, et al. Assessment of environmental enteric dysfunction in the SHINE trial: Methods and challenges. Clin Infect Dis 2015; 61(suppl 7):S726-32.
4. Prendergast A, Kelly P. Enteropathies in the developing world: Neglected effects on global health. Am J Trop Med Hyg 2012; 86:756-63.
5. Prendergast AJ, Humphrey JH. The stunting syndrome in developing countries. Paediatr Int Child Health 2014; 34:250-65.
6. Smith L, Stoltzfus R, Prendergast A. Food-chain mycotoxin exposure, gut health and impaired growth: A conceptual framework. Adv Nutr 2012; 3:1-6.
7. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr 2004; 80:1106-22.
8. Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev 2003; 16:497-516.
9. Lamplugh SM, Hendrickse RG, Apeagyei F, Mwanmut DD. Aflatoxins in breast-milk, neonatal cord blood, and serum of pregnant women. Br Med J 1988; 296:968.
10. Maxwell SM, Familusi JB, Sodeinde O, Chan MCK, Hendrickse RG. Detection of naphthols and aflatoxins in Nigerian cord-blood. Ann Trop Paediatr 1994; 14:3-5.
11. Jonsyn FE, Maxwell SM, Hendrickse RG. Human fetal exposure to ochratoxin-a and aflatoxins. Ann Trop Paediatr 1995; 15:3-9.
12. Denning DW, Allen R, Wilkinson AP, Morgan MRA. Transplacental transfer of aflatoxin in humans. Carcinogenesis 1990; 11:1033-5.
13. Abulu EO, Uriah N, Aigbefo HS, Oboh PA, Agbonlahor DE. Preliminary investigation on aflatoxin in cord blood of jaundiced neonates. West Afr J Med 1998; 17:184-7.
14. Abdulrazzaq YM, Osman N, Ibrahim A. Fetal exposure to aflatoxins in the United Arab Emirates. Ann Trop Paediatr 2002; 22:3-9.
15. Abdulrazzaq YM, Osman N, Yousif ZM, Trad O. Morbidity in neonates of mothers who have ingested aflatoxins. Ann Trop Paediatr 2004; 24:145-51.
16. Gong YY, Cardwell K, Hounsa A, et al. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: Cross sectional study. Br Med J 2002; 325:20-1.
17. Groopman JD, Egner PA, Schulze KJ, et al. Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin b-lysine albumin biomarkers. Food Chem Toxicol 2014; 9:00417-7.
18. Turner PC, Collinson AC, Cheung YB, et al. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol 2007; 36:1119-25.
19. Gong YY, Hounsa A, Egal S, et al. Postweaning exposure to aflatoxin results in impaired child growth: A longitudinal study in Benin, West Africa. Environ Health Perspect 2004; 112:1334-8.
20. Dewey KG, Adu-Afarwuah S. Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutrn 2008; 4:24-85.
21. Bouhet S, Oswald IP. The intestine as a possible target for fumonisin toxicity. Mol Nutr Food Res 2007; 51:925-31.
22. Gong YY, Torres-Sanchez L, Lopez-Carrillo L, et al. Association between tortilla consumption and human urinary fumonisin B1 levels in a Mexican population. Cancer Epidemiol Biomarkers Prev 2008; 17:688-94.
23. Shirima CP, Kimanya ME, Routledge MN, et al. A prospective study of growth and biomarkers of exposure to aflatoxin and fumonisin during early childhood in Tanzania. Environ Health Perspect 2015; 123:173.
24. Rotter BA, Thompson BK, Lessard M. Effects of deoxynivalenolcontaminated diet on performance and blood parameters in growing swine. Can J Anim Sci 1995; 75:297-302.
25. Amuzie CJ, Pestka JJ. Suppression of insulin-like growth factor acidlabile subunit expression-a novel mechanism for deoxynivalenolinduced growth retardation. Toxicol Sci 2010; 113:412-21.
26. Srey C, Kimanya ME, Routledge MN, Shirima CP, Gong YY. Deoxynivalenol exposure assessment in young children in Tanzania. Mol Nutr Food Res 2014; 58:1574-80.
27. Piekkola S, Turner PC, Abdel-Hamid M, et al. Characterisation of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2012; 29:962-71.
28. Abia WA, Warth B, Sulyok M, et al. Determination of multi-mycotoxin occurrence in cereals, nuts and their products in Cameroon by liquid chromatography tandem mass spectrometry (LC-MS/MS). Food Control 2013; 31:438-53.
29. Ezekiel CN, Warth B, Ogara IM, et al. Mycotoxin exposure in rural residents in northern Nigeria: A pilot study using multi-urinary biomarkers. Environ Int 2014; 66:138-45.
30. Bracarense A, Lucioli J, Grenier B, et al. Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br J Nutr 2012; 107:1776-86.
31. Qian GQ, Tang LL, Guo X, et al. Aflatoxin b-1 modulates the expression of phenotypic markers and cytokines by splenic lymphocytes of male f344 rats. J Appl Toxicol 2014; 34:241-9.
32. Chaytor AC, See MT, Hansen JA, De Souza ALP, Middleton TF, Kim SW. Effects of chronic exposure of diets with reduced concentrations of aflatoxin and deoxynivalenol on growth and immune status of pigs. J Anim Sci 2011; 89:124-35.
33. MeissonnierGM, Pinton P, Laffitte J, et al. Immunotoxicity of aflatoxin b1: Impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression. Toxicol Appl Pharmacol 2008; 231:142-9.
34. Li Y, Ma QG, Zhao LH, et al. Effects of lipoic acid on immune function, the antioxidant defense system, and inflammation-related genes expression of broiler chickens fed aflatoxin contaminated diets. Int J Mol Sci 2014; 15:5649-62.
35. Gratz S, Wu QK, El-Nezami H, Juvonen RO, Mykkanen H, Turner PC. Lactobacillus rhamnosus strain GG reduces aflatoxin b1 transport, metabolism, and toxicity in caco-2 cells. Appl Environ Microbiol 2007; 73:3958-64.
36. Bruns HA. Controlling aflatoxin and fumonisin in maize by crop management. Toxin Rev 2003; 22:153-73.
37. Hell K, Cardwell K, Setamou M, Poehling H-M. The influence of storage practices on aflatoxin contamination in maize in four agroecological zones of Benin, West Africa. J Stored Prod Res 2000; 36:365-82.
38. Makasa M, Kasonka L, Chisenga M, et al. Early growth of infants of HIV-infected and uninfected Zambian women. Trop Med Int Health 2007; 12:594-602.
39. Gerding J, Ali N, Schwartzbord J, et al. A comparative study of the human urinary mycotoxin excretion patterns in Bangladesh, Germany, and Haiti using a rapid and sensitive LC-MS/MS approach. Mycotoxin Res 2015; 10:10.
40. Scholl PF, Mccoy L, Kensler TW, Groopman JD. Quantitative analysis and chronic dosimetry of the aflatoxin B-1 plasma albumin adduct lysafb( 1) in rats by isotope dilution mass spectrometry. Chem Res Toxicol 2006; 19:44-9.
41. Turner PC. The molecular epidemiology of chronic aflatoxin driven impaired child growth. Scientifica 2013; 152879:19.
42. Turner PC, Rothwell JA, White KLM, Gong Y, Cade JE, Wild CP. Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom. Environ Health Perspect 2008; 116:21-5.
43. Mackinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol 2007; 58:593-614.
44. Vittinghoff E, Sen S, Mcculloch CE. Sample size calculations for evaluating mediation. Stat Med 2009; 28:541-57.